Matti Höyhtyä

Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome.

Sirkka Liisa Hostikka, Roger L. Eddy, M.G. Byers et al. · Proceedings of the National Academy of Sciences · 1990 · 387 citations

Life Sciences, Genetics, Molecular Biology +15

Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions.

Rafael Fridman, Thomas R. Fuerst, Robert E. Bird et al. · Journal of Biological Chemistry · 1992 · 202 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.

S Ylisirniö, Matti Höyhtyä, Taina Turpeenniemi‐Hujanen · PubMed · 2000 · 170 citations

Medicine, Oncology, Pathology +15

Enhanced expression of tissue inhibitor of metalloproteinase‐2 (TIMP‐2) in the stroma of breast carcinomas correlates with tumor recurrence

Daniel W. Visscher, Matti Höyhtyä, Susan Ottosen et al. · International Journal of Cancer · 1994 · 168 citations

Medicine, Oncology, Pathology +17

<i>Immunohistochemical local</i>ization of matrix metallloproteinase 2 and its specific inhibitor timp‐2 in neoplastic tissues with monclonal antibodies

Matti Höyhtyä, Rafiae L Fripman, Daniel Komarek et al. · International Journal of Cancer · 1994 · 137 citations

Medicine, Oncology, Pathology +12